Ketoconazole treatment of 13 patients with chronic mucocutaneous candidiasis. A prospective 3-year trial.

Long-term results of initial ketoconazole treatment were evaluated in 13 patients with chronic mucocutaneous candidiasis followed up for 3 years. Six of them shared 11 endocrine or autoimmune disorder